Emerging Biosensor Technologies for Stroke Biomarker Detection: A Comprehensive Overview
Open Access
- 12 August 2025
- journal article
- review article
- Published by Wiley in Analytical Science Advances
- Vol. 6 (2) , e70035
Abstract
Stroke remains a leading cause of morbidity and mortality worldwide, necessitating the development of rapid and reliable diagnostic tools for early detection and management. This manuscript presents an overview of innovative biosensors designed for the detection of key stroke biomarkers, including N‐terminal pro B‐type natriuretic peptide (NT‐proBNP), C‐reactive protein (CRP), D‐dimer, cardiac troponins, S100B protein, glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), matrix metalloproteinases (MMPs), interleukins and fibrinogen. We discuss the principles of operation, sensitivity, specificity and the technological advancements that have enabled the development of these biosensors, including electrochemical, optical and microfluidic platforms. The integration of nanomaterials and advanced signal amplification techniques has significantly enhanced the performance of these biosensors, allowing for the detection of biomarkers at low concentrations in complex biological samples. Furthermore, we explore the clinical implications of these biosensors in the context of stroke diagnosis, prognosis and monitoring, highlighting their potential to facilitate timely therapeutic interventions. By providing a comprehensive discussion on the current state of biosensor technology for stroke biomarker detection, this manuscript aims to underscore the importance of these tools in improving patient outcomes and advancing stroke research. Future directions for biosensor development and the challenges that remain in translating these technologies into clinical practice are also addressed.Keywords
This publication has 78 references indexed in Scilit:
- Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified SurfaceSensors, 2021
- Electrochemical dual-aptamer-based biosensor for nonenzymatic detection of cardiac troponin I by nanohybrid electrocatalysts labeling combined with DNA nanotetrahedron structureBiosensors and Bioelectronics, 2019
- Dual mode competitive electrochemical immunoassay for B-type natriuretic peptide based on GS/SnO2/polyaniline-Au and ZnCo2O4/N-CNTsBiosensors and Bioelectronics, 2019
- A photoelectrochemical sandwich immunoassay for protein S100β, a biomarker for Alzheimer’s disease, using an ITO electrode modified with a reduced graphene oxide-gold conjugate and CdS-labeled secondary antibodyMicrochimica Acta, 2019
- Electrochemical Aptamer-Based Biosensors for the Detection of Cardiac BiomarkersACS Omega, 2018
- Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and researchCritical Reviews in Clinical Laboratory Sciences, 2018
- High sensitivity cardiac troponin I detection in physiological environment using AlGaN/GaN High Electron Mobility Transistor (HEMT) BiosensorsBiosensors and Bioelectronics, 2018
- Voltammetric Detection of S100B Protein Using His-Tagged Receptor Domains for Advanced Glycation End Products (RAGE) Immobilized onto a Gold Electrode SurfaceSensors, 2014
- A Blood-based Biomarker Panel to Detect Acute StrokeJournal of Stroke and Cerebrovascular Diseases, 2014
- Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canisin miceBMC Infectious Diseases, 2008